Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-755 in Acute Ischemic Stroke
NCT07392450Phase 2Recruiting
- Sponsor
- Takeda
- Start
- May 2026
- Primary completion
- Dec 2027
- Modality
- Replacement Enzymes
- Countries
- 10
01
Overview
A Phase 2 trial of Apadamtase alfa in ischemic stroke, sponsored by Takeda. Started May 2026; status: recruiting.
02
Drugs
Apadamtase alfa
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07392450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07392450.